Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04631211Phase 2Terminated
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
Bone Marrow AplasiaHematologic MalignancyMyelodysplastic Syndromes+3 more
StudydirectorStart date: 2021-03-05

Research Network

Collaboration Network

33 collaborators·32 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Terry Gernsheimer, MD

University of Washington

Similar
4 trials

Shared therapeutic areas:

ThrombocytopeniaBone Marrow AplasiaHematologic Neoplasms+3 more

Worked with same sponsors:

Cellphire Therapeutics, Inc.Department of Health and Human Services
Collaborated on 1 trial
Similarity Score64%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Hematologic NeoplasmsMyelodysplastic SyndromesMyeloproliferative Disorders
Similarity Score15%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hematologic NeoplasmsMyelodysplastic SyndromesMyeloproliferative Disorders
Similarity Score15%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesHematologic NeoplasmsMyeloproliferative Disorders
Similarity Score15%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Hematologic NeoplasmsMyelodysplastic Syndromes
Similarity Score10%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Myelodysplastic SyndromesMyeloproliferative Disorders
Similarity Score10%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Hematologic NeoplasmsMyelodysplastic Syndromes
Similarity Score10%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Myelodysplastic SyndromesHematologic Neoplasms
Similarity Score10%

Neal S Young, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Myelodysplastic SyndromesThrombocytopenia
Similarity Score10%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Myelodysplastic SyndromesMyeloproliferative Disorders
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04631211Phase 2StudyDirector

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Bone Marrow AplasiaHematologic MalignancyMyelodysplastic Syndromes+3 more
Terminated

All 1 trials loaded